Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant plasmodium falciparum isolates

Acta Tropica

Volumn 66, Issue 3, 1997, Pages 127-135

  Edstein, M D ^a   Yeo, A E T ^a   Shanks, G D ^a,b   Rieckmann, K H ^a  

^a AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

Cycloguanil; Dapsone; Drug resistance; In vitro activity; Plasmodium falsiparum; Proguanil

Indexed keywords

CYCLOGUANIL; DAPSONE; PROGUANIL;

ADULT; ANTIMALARIAL ACTIVITY; ARTICLE; AUSTRALIA; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG MIXTURE; HUMAN; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MILITARY MEDICINE; OCCUPATIONAL HEALTH; PLASMODIUM FALCIPARUM; SOLDIER; THAILAND; VOLUNTEER;

ANIMALS; ANTIMALARIALS; CHLOROGUANIDE; DAPSONE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; TRIAZINES;

PLASMODIUM FALCIPARUM;

EID: 0030811149     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(97)00044-2     Document Type: Article

References (25)

1. Basco L.K., Ramiliarisoa O., Ringwald P., Thor R. Doury, J-C., Le Bras, J. Activity in vitro of chloroquine, cycloguanil, and mefloquine against African isolates of Plasmodium falciparum: presumptive evidence for chemoprophylactic efficacy in Central and West Africa. Trans. R. Soc. Trop. Med. Hyg. 89:1995;657-658.
2. Black R.H. Malaria in the Australian Army in South Vietnam. Med. J. Aust. 1:1973;1265-1270.
3. Black R.H., Ray A.P. Experimental studies of the potentiation of proguanil and pyrimethamine by dapsone using Plasmodium berghei in white mice. Ann. Trop. Med. Parasitol. 71:1977;131-139.
4. Brosen K., Skjelbo E., Flachs H. Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark. Br. J. Clin. Pharmacol. 36:1993;105-108.
5. Brown G.V. Tropical Health. Chemoprophylaxis of malaria. Med. J. Aust. 159:1993;187-196.
6. Edstein M.D., Rieckmann K.H., Veenendaal J.R. Multiple-dose pharmacokinetics and in vitro antimalarial activity of dapsone plus pyrimethamine (Maloprim®) in man. Br. J. Clin. Pharmacol. 30:1990;259-265.
7. Edstein M.D., Shanks G.D., Teja-Isavadharm P., Rieckmann K.H., Webster H.K. Oxidative activation of proguanil and dapsone acetylation in Thai soldiers. Br. J. Clin. Pharmacol. 37:1994;67-70.
8. Edstein, M.D., Looareesuwan, S., Wilairatana, P., Vanijanonta, S., Kyle, D.E., Rieckmann, K.H. (1997) Disposition of proguanil in Thai patients with uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg., in press.
9. Helsby N.A., Ward S.A., Edwards G., Howells R.E., Breckenridge A.M. The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism. Br. J. Clin. Pharmacol. 30:1990;593-598.
10. Helsby N.A., Edwards G., Breckenridge A.M., Ward S.A. The multiple dose pharmacokinetics of proguanil. Br. J. Clin. Pharmacol. 35:1993;653-656.
11. Karwacki J.J., Shanks G.D., Suriyamongkol V., Watanasook C. Proguanil/sulfamethoxazole malaria chemoprophylaxis on the Thai-Cambodian border. Southeast. Asian. J. Trop. Med. Public. Health. 22:1991;77-80.
12. Lambros C., Vanderberg J.P. Sychronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:1979;418-420.
13. Mberu E.K., Wansor T., Sato H., Nishikawa Y., Watkins W.M. Japanese poor metabolizers of proguanil do not have an increased risk of malaria chemoprophylaxis breakthrough. Trans. R. Soc. Trop. Med. Hyg. 89:1995;658-659.
14. Milhous, W.K. Gerena, L., Kyle, D.E., Oduola, A.M.J., 1989. In vitro strategies for circumventing antimalarial drug resistance. In: Liss A.R. (Ed.), Malaria and the Red Cell 2; Progress Clin. Biol. Res., 313, 61-72.
15. Oduola A.M.J., Weatherly N.F., Bowdre J.H., Desjardins R.E. Plasmodium falciparum: Cloning by single-erythrocytic micromanipulation and heterogenicity in vitro. Exp. Parasitol. 66:1988;86-95.
16. Pang L.W., Limsomwong N., Singharaj P., Canfield C.J. Malaria prophylaxis with proguanil and sulfisoxazole in children living in an endemic area. Bull. WHO. 67:1989;51-58.
17. Schapira A. Concomitant resistance to pyrimethamine and cycloguanil of chloroquine-resistant falciparum malaria from East Africa: an in vitro study of 12 isolates. Trans. R. Soc. Trop. Med. Hyg. 78:1984;359-362.
18. Scott H.V., Rieckmann K.H., O'Sullivan W.J. Synergistic antimalarial activity of dapsone/dihydrofolate reductase inhibitors and the interaction of antifol, antipyrimidine and antipurine combinations against Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 81:1987;715-721.
19. Scott H.V., Edstein M.D., Veenendaal J.R., Rieckmann K.H. A sensitive bioassay for serum cycloguanil using Plasmodium falciparum in vitro. Int. J. Parasitol. 18:1988;605-609.
20. Shanks G.D., Edstein M.D., Suriyamongkol V., Timsaad S., Webster H.K. Malaria chemoprophylaxis using proguanil/dapsone combinations on the Thai-Cambodian border. Am. J. Trop. Med. Hyg. 46:1992;643-648.
21. Shanks G.D., Edstein M.D., Chedester A.L., Smith C.D., Corcoran K.D., Ngampochjana M., Hansukjariya P., Sattabongkot J., Webster H.K. Proguanil plus sulfamethoxazole is not causally prophylactic in the Macaca mulatta-Plasmodium cynomolgi. Am. J. Trop. Med. Hyg. 50:1994;641-645.
22. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science. 193:1976;673-675.
23. Ward S.A., Watkins W.M., Mberu E., Saunders J.E., Koeck D.K., Gilles H.M., Howells R.E., Breckenridge A.M. Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man. Br. J. Clin. Pharmacol. 27:1989;781-787.
24. Watkins W.M., Howells R.E., Brandling-Bennett D.K., Koech D.K. In vitro susceptibility of Plasmodium falciparum isolates from Jilore, Kenya, to antimalarial drugs. Am. J. Trop. Med. Hyg. 37:1987;445-451.
25. Watkins W.M., Mberu E.K., Nevill C.G., Ward S.A., Breckenridge A.M., Koech D.K. Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults. Trans. R. Soc. Trop. Med. Hyg. 84:1989;492-495.